Apollo Endosurgery Inc EBITDA margin
Was ist das EBITDA margin von Apollo Endosurgery Inc?
EBITDA margin von Apollo Endosurgery Inc ist -60.86%
Was ist die Definition von EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Apollo Endosurgery Inc
Was macht Apollo Endosurgery Inc?
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Unternehmen mit ebitda margin ähnlich Apollo Endosurgery Inc
- Megalith hat EBITDA margin von -61.33%
- Sailfish Royalty hat EBITDA margin von -61.30%
- Echo Plc hat EBITDA margin von -61.25%
- Avita Medical hat EBITDA margin von -61.20%
- Hutchison China MediTech hat EBITDA margin von -61.12%
- Tu Yi hat EBITDA margin von -60.99%
- Apollo Endosurgery Inc hat EBITDA margin von -60.86%
- Aurinia Pharmaceuticals hat EBITDA margin von -60.84%
- Hostelworld plc hat EBITDA margin von -60.83%
- Taal Distributed Information Technologies hat EBITDA margin von -60.81%
- Weimob hat EBITDA margin von -60.69%
- Cluey Ltd hat EBITDA margin von -60.68%
- Waterdrop hat EBITDA margin von -60.59%